4
Changes in Ownership
GENELUX Corp Filed Acc 0001209191-23-056455
VP, Clinical Trial Operations sold 18,665 shares at $10.26 ($191,555)
From the SEC's structured data for this filing
Trades in this filing
Yu Yong · VP, Clinical Trial Operations
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-21 | Sale : show line 1 in the form | −18,665 | $10.26 | $191,555 | 69,335 | D |
| Open-market sales · 18,665 sh · avg $10.26 · $191,555 | ||||||
Loading xslF345X05/doc4.xml…